Crossref
Clinical suspicion, pharmacovigilance, and pharmacogenetics in the prevention of severe outcomes of febrile neutropenia
Therapy · 16.11.2026 · 8_2026 · 70-78
DOI: 10.18565/therapy.2026.8.70-78 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapy, erschienen am 16.11.2026. Verfasst von E.I. Busalaeva Busalaeva und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Busalaeva, E. B., Zhuchkova, S. Z., & Gromova, G. G. (2026). Clinical suspicion, pharmacovigilance, and pharmacogenetics in the prevention of severe outcomes of febrile neutropenia. Therapy, 8_2026, 70-78. https://doi.org/10.18565/therapy.2026.8.70-78
Vancouver
Busalaeva EB, Zhuchkova SZ, Gromova GG. Clinical suspicion, pharmacovigilance, and pharmacogenetics in the prevention of severe outcomes of febrile neutropenia. Therapy. 2026;8_2026:70-78. doi:10.18565/therapy.2026.8.70-78
BibTeX
@article{Busalaeva2026,
author = {Busalaeva, E.I. Busalaeva and Zhuchkova, S.M. Zhuchkova and Gromova, G.A. Gromova},
title = {Clinical suspicion, pharmacovigilance, and pharmacogenetics in the prevention of severe outcomes of febrile neutropenia},
journal = {Therapy},
year = {2026},
volume = {8_2026},
pages = {70--78},
doi = {10.18565/therapy.2026.8.70-78}
}
EUVIMED